Bioadhesive poly(methyl methacrylate) microdevices for controlled drug delivery

Journal of Controlled Release

Volumn 88, Issue 2, 2003, Pages 215-228

  Tao, Sarah L ^a,b   Lubeley, Michael W ^a   Desai, Tejal A ^a,b  

^a University of Illinois at Chicago   (United States)

^b Boston University   (United States)

Author keywords

Bioadhesive; Lectin; Microfabrication; Microparticles; Oral delivery

Indexed keywords

AMINE; AVIDIN; CYANAMIDE; LECTIN; POLY(METHYL METHACRYLATE); SUCCINIMIDE DERIVATIVE;

AQUEOUS SOLUTION; ARTICLE; ATOMIC FORCE MICROSCOPY; BIOTINYLATION; CATALYST; CHEMICAL MODIFICATION; CONTROLLED STUDY; COVALENT BOND; DEVICE; DRUG DELIVERY SYSTEM; FLUORESCENCE MICROSCOPY; GASTROINTESTINAL TRACT; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; PRIORITY JOURNAL; X RAY PHOTOELECTRON SPECTROSCOPY;

EID: 0037423774     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00005-1     Document Type: Article

References (31)

1. Lavelle E.C. Targeted delivery of drugs to the gastrointestinal tract. Crit. Rev. Ther. Drug Carrier Syst. 18:2001;341-386.
2. Saffran M., Kumar G.S., Neckers D.C., Pena J., Jones R.H., Field J.B. Biodegradable azopolymer coating for oral delivery of peptide drugs. Biochem. Soc. Trans. 18:1990;752-754.
3. Iwanaga K., Ono S., Narioka K., Kakemi M., Morimoto K., Yamashita S., Namba Y., Oku N. Application of surface-coated liposomes for oral delivery of peptide: effect of coating the liposome's surface on the GI transit of insulin. J. Pharm. Sci. 88:1999;248-252.
4. Ponchel G., Irache J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. 34:1998;191-219.
5. Arrangoa M.A., Ponchel G., Orecchioni A.M., Renedo M.J., Duchene D., Irache J.M. Bioadhesive potential of gliadin nanoparticulate systems. Eur. J. Pharm. Sci. 11:2000;333-341.
6. Lehr C.M. Lectin-mediated drug delivery: the second generation of bioadhesives. J. Control. Release. 65:2000;19-29.
7. Fasano A., Uzzau S. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J. Clin. Invest. 99:1997;1158-1164.
8. Schwarz U.I., Gramatte T., Krappweis J., Oertel R., Kirch W. P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans. Int. J. Clin. Pharmacol. Ther. 38:2000;161-167.
9. Jaeger R. Introduction to Microelectronic Fabrication. 1993;Addison-Wesley, Reading, MA.
10. Deutsch J., Motlagh D., Russell B., Desai T.A. Fabrication of microtextured membranes for cardiac myocyte attachment and orientation. J. Biomed. Mater. Res. 53:2000;267-275.
11. Desai T.A., Chu W.H., Tu J.K., Beattie G.M., Hayek A., Ferrari M. Microfabricated immunoisolating biocapsules. Biotechnol. Bioeng. 57:1998;118-120.
12. Desai T.A. Micro- and nanoscale structures for tissue engineering constructs. Med. Eng. Phys. 22:2000;595-606.
13. Leoni L., Desai T.A. Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility considerations. IEEE Trans. Biomed. Eng. 48:2001;1335-1341.
14. Santini J.T., Richards A.C., Scheidt R.A., Cima M.J., Langer R.S. Microchip technology in drug delivery. Ann. Med. 32:2000;377-379.
15. Santini J.T., Richards A.C., Scheidt R., Cima M.J., Langer R. Microchips as controlled drug-delivery devices. Angew Chem. Int. Ed. 39:2000;2396-2407.
16. Santini J.T., Cima M.J., Langer R. A controlled-release microchip. Nature. 397:1999;335-338.
17. Polla D.L., Erdman A.G., Robbins W.P., Markus D.T., Diaz-Diaz J., Rizq R., Nam Y., Brickner H.T. Microdevices in medicine. Annu. Rev. Biomed. Eng. 2:2000;551-576.
18. McAllister D.V., Allen M.G., Prausnitz M.R. Microfabricated microneedles for gene and drug delivery. Annu. Rev. Biomed. 2:2000;289-313.
19. Lieppmann D., Pisano A.P., Sage B. Microelectromechanical systems technology to deliver insulin. Diabetes Technol. Ther. 1:1999;469-476.
20. Low L., Seetharaman S., He K., Madou M.J. Microactuators toward microvalves for responsive controlled drug delivery. Sens. Actuat. B Chem. 67:2000;149-160.
21. Mody R., Joshi S., Chaney W. Use of lectins as diagnostic and therapeutic tools for cancer. J. Pharmacol. Toxicol. Methods. 33:1996;1-10.
22. Pusztai A. Lectin-targeting of microparticles to different parts of the gastrointestinal tract. Proc. Int. Symp. Control. Rel. Bioact. Mater. 22:1995;161-162.
23. Carreno-Gomez B., Woodley J.F., Florence A.T. Studies on the uptake of tomato lectin nanoparticles in everted gut sacs. Int. J. Pharm. 183:1999;7-11.
24. Kilpatrick D., Pusztai A., Grant G., Graham C., Ewen S. Tomato lectin resists digestion in the mammalian alimentary canal and binds to intestinal villi without deleterious effects. FEBS Lett. 185:1985;299-305.
25. Ahmed A., Bonner C., Desai T.A. Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery. J. Control. Release. 81:2002;291-306.
26. Karandikar B., Puschett J. Homogeneous and heterogeneous modification of poly(methyl methacrylate) with ethylene diamine. Polym. Prep. 30:1989;250-251.
27. Henry A., Tutt T., Galloway M., Davidson Y., McWhorter S., Soper S., McCarley R. Surface modification of poly(methyl methacrylate) used in the fabrication of microanalytical devices. Anal. Chem. 72:2000;5331-5337.
28. Sultzbaugh K.J., Speaker T.J. A method to attach lectins to the surface of spermine alginate microcapsules based on the avidin biotin interaction. J. Microencapsul. 13:1996;363-375.
29. Lehr C.M., Bouwstra J., Kok W., Noach A., Boer A., Junginger H. Bioadhesion by means of specific binding to tomato lectin. Pharm. Res. 9:1992;547-553.
30. Russell-Jones G.J., Veitch H., Arthur L. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int. J. Pharm. 190:1999;165-174.
31. Gabor F., Stangl M., Wirth M. Lectin-mediated bioadhesion: binding characteristics of plant lectins on the enterocyte-like cell lines Caco-2, HT-29 and HCT-8. J. Control. Release. 55:1998;131-142.